MARSHALL WACE, LLP - ORAMED PHARMACEUTICALS INC ownership

ORAMED PHARMACEUTICALS INC's ticker is ORMP and the CUSIP is 68403P203. A total of 46 filers reported holding ORAMED PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 0.29 and the average weighting 0.1%.

Quarter-by-quarter ownership
MARSHALL WACE, LLP ownership history of ORAMED PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$23,006
-94.9%
10,553
-71.8%
0.00%
-100.0%
Q4 2022$449,909
+143.2%
37,399
+31.6%
0.00%
Q3 2022$185,000
+105.6%
28,409
+45.6%
0.00%
Q2 2022$90,000
-23.1%
19,509
+68.7%
0.00%
-100.0%
Q1 2021$117,000
-24.5%
11,563
-68.4%
0.00%0.0%
Q4 2020$155,000
+1.3%
36,632
-37.5%
0.00%0.0%
Q3 2020$153,000
-10.0%
58,648
+21.5%
0.00%0.0%
Q2 2020$170,000
-27.7%
48,260
-37.6%
0.00%
-50.0%
Q1 2020$235,000
-59.9%
77,361
-32.0%
0.00%
-50.0%
Q4 2019$586,000113,7060.00%
Other shareholders
ORAMED PHARMACEUTICALS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Acrospire Investment Management LLC 8,355$61,0000.04%
TOCQUEVILLE ASSET MANAGEMENT L.P. 70,000$508,0000.01%
Financial Architects, Inc 2,000$15,0000.00%
FineMark National Bank & Trust 3,473$25,0000.00%
JFS WEALTH ADVISORS, LLC 1,000$7,0000.00%
Penserra Capital Management LLC 2,540$18,0000.00%
Tower Research Capital LLC (TRC) 1,284$10,0000.00%
SIMPLEX TRADING, LLC 2,673$19,0000.00%
Plante Moran Financial Advisors, LLC 300$2,0000.00%
Cutler Group LLC / CA 2,404$17,0000.00%
View complete list of ORAMED PHARMACEUTICALS INC shareholders